Abiopharma

🔍 House Rebecca W (Director)

Company: Marvell Technology, Inc. (MRVL)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 1,034 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,034.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.
• F2: Vests in full on the earlier of Marvell Technology, Inc.'s next annual meeting of stockholders or the one-year anniversary of the restricted stock unit grant date.